Top Stories

• 

  Ashurst, Perkins Coie To Form $2.7B Giant In US-UK Deal

  By Marialuisa Taddia

  The U.K.'s Ashurst LLP and U.S.-based Perkins Coie LLP said Monday that they have agreed to merge to form a new ...(read more)

• 

  Apple Hit With $634M Verdict Over Masimo Health Tech Patent

  By Craig Clough

  A California federal jury on Friday awarded Masimo Corp. more than $634 million from Apple Inc. following an eig...(read more)

ADVERTISEMENT


• Judge Tests DOJ Claim That TPS Decisions Can't Be Reviewed

  By Britain Eakin

  A New York federal judge Monday grilled a government attorney over the Trump administration's termination of temporary protected status for Syrians, pressing him on the outer limits of judicial review of such decisions.

• Holyoak Leaves FTC For Interim U.S. Atty In Utah

  By Bryan Koenig

  Melissa Holyoak left the Federal Trade Commission on Monday to become Utah's interim U.S. attorney, leaving the FTC down to two commissioners, both Republicans, in the Trump administration's latest use of interim U.S. attorney appointments.

• Judge Rebukes DOJ Over Defiance In Abrego Garcia Case

  By Jared Foretek

  A Maryland federal judge on Monday blasted U.S. Department of Justice attorneys looking to send Kilmar Abrego Garcia to Liberia, saying they were asking her to countenance testimony that Costa Rica would not accept the Salvadoran national absent "additional commitments" from the U.S., without explaining how the conclusion was reached.

• EPA, Army Corps Float Trimming Clean Water Act Powers

  By Juan-Carlos Rodriguez

  The U.S. Environmental Protection Agency and Army Corps of Engineers on Monday proposed new limits on their ability to enforce the Clean Water Act, saying prior understandings of the federal government's authority were too broad.

• Cravath, Goodwin Advise On J&J's $3B Cancer Drug Play

  By Al Barbarino

  Cravath-advised Johnson & Johnson said Monday it has agreed to pay $3.05 billion in cash for Goodwin-led Halda Therapeutics, a biotech developing a clinical-stage therapy for prostate cancer.

• DOJ Backs White House's Military Lawyer Transfers

  By Courtney Bublé

  A newly released legal opinion from the U.S. Department of Justice says the Trump administration is allowed to detail military lawyers to serve as immigration judges and special assistant U.S. attorneys in the District of Columbia.

• Ex-Boxer's Cocaine Trial Off After Jury Tampering Arrests

  By Pete Brush

  A Brooklyn federal judge on Monday dismissed a jury that had been set to hear the government's $1 billion cocaine trafficking case against a former heavyweight boxer, after three Staten Island men were arrested for allegedly trying to bribe a juror.

• 3 Firms Steer Mitsui's $1.44B Minority Stake In Barings

  By Jade Martinez-Pogue

  Japanese insurance company Mitsui Sumitomo Insurance Co. Ltd. on Monday announced that it has agreed to take a minority stake in MassMutual-owned asset management firm Barings LLC in a $1.44 billion deal built by three law firms.

• Diamond Co. Lugano Hits Ch. 11 With $500M+ Debt, Sale Plans

  By Emlyn Cameron and Emily Lever

  Luxury jewelry house Lugano Diamonds & Jewelry Inc. has hit Chapter 11 in Delaware with more than $680 million in debt as it seeks to recover from its former CEO's alleged fraudulent diamond transactions.

• 3 Firms Advising On CD&R's $10.3B Bubble Wrap Maker Buy

  By Al Barbarino

  Private equity firm CD&R has agreed to purchase Sealed Air Corp., a provider of packaging solutions including Bubble Wrap and Cryovac, at an enterprise value of $10.3 billion in a deal steered by three law firms, Sealed Air said in a Monday announcement.

• Justices Pass On Avianca's Ch. 11 Lease Obligation Appeal

  By Clara Geoghegan

  The U.S. Supreme Court on Monday declined to take up Latin America airline Avianca's challenge to the Second Circuit's decision that aircraft lease broker fees that became due during its Chapter 11 were administrative expense claims, not general unsecured claims.

• SEC Gives Cos. Freer Rein To Block Shareholder Proposals

  By Jessica Corso

  The U.S. Securities and Exchange Commission announced Monday that it will not review most of the requests it gets from publicly traded companies hoping to exclude shareholder proposals from corporate ballots this proxy season, saying that it will not object to the exclusions due to time and resource constraints.